June 2008 Vol XXXII Issue 6

Previous MonthNext Month


Management of Hyperemesis Gravidarum with Enteral Nutrition

Linda M. Lord, Kim Pelletier

Hyperemesis gravidarum is the most severe form of nausea and emesis during pregnancy and can be harmful to both the pregnant woman and her fetus. This article reviews the diet, medications and use of enteral feeding in these patients.


Preventive Approaches in Chronic Liver Disease
Part III: Decompensated Liver Cirrhosis

Mohammad R. Taheri, Thomas R. Riley III

Part II of this series covered compensated liver disease. Compensated liver disease becomes decompensated at a rate of five-to-ten percent yearly. Liver transplantation is the only prospect for long-term survival in patients with decompensated cirrhosis. The main objective of this article is to provide strategies to the caregiver that will help to detect and avoid complications in patients before liver transplantation.


Hirschsprung's Disease

Lakshmi Pasumarthy, James W. Srour

Hirschsprung's Disease is an unusual but well-recognized cause of chronic constipation in young children, most often boys. This article covers the genetics, signs, symptoms and epidemiology of this disease.

Departments Section

Medical Bulletin Board

Quest Diagnostics Campaign Challenges
Colorectal Cancer Screening Status Quo

Do You Have the Guts? Aims to Reach Five Million in Five Years
Quest Diagnostics Incorporated has launched a campaign designed to help increase compliance with take-home colorectal screening tests.

Colorectal Cancer Screening Guidelines of the American Cancer Society Include EXACT Sciences' Stool DNA Technology

Non-invasive Screening Option Has Potential to Save More Lives
EXACT Sciences Corporation announced the company's non-invasive, stool-based DNA (sDNA) technology is included in the American Cancer Society's (ACS) updated guidelines for colorectal cancer screening.

IFFGD is Seeking Applications for 2009 Research Awards

IFFGD is seeking applications/nominations for research awards. The awards will be given to active investigators in six categories who have a record of research interest in basic mechanisms or clinical aspects of functional gastrointestinal and motility disorders, and neurogastroenterology.

ASGE Re-Launches Colon Cancer Awareness Web Site www.Screen4coloncancer.Org for National Colorectal Cancer Awareness Month

Site Features Updated Information on Colon Cancer Prevention and a New Birthday e-Card that Reminds Those 50 and Over to Get Screened

Cancer Detected Earlier, Faster, with New Medical Imaging, Stanford Study Finds

Doctors may one day be able to detect early stages of colon cancer without a biopsy, using a new technique developed by researchers at the Stanford University School of Medicine.

Shire and TAP Agree to Co-promote LIALDATM (Mesalamine), the First Oral Once-Daily Mesalamine for Patients With Active, Mild to Moderate Ulcerative Colitis

Shire has announced a co-promotion agreement with TAP Pharmaceutical Products Inc. for LIALDATM (mesalamine) with MMX® technology, indicated for the induction of remission in patients with active, mild to moderate ulcerative colitis (UC).

From the Literature

Comparison of Imaging Techniques for Endoscopy in Barrett's Esophagus

In order to compare magnified still images obtained with high-resolution endoscopy, indigo carmine chromoendoscopy, acetic acid chromoendoscopy and narrow band imaging (NBI) to determine the best technique for use in Barrett's esophagus, magnified images from 22 areas with the aforementioned techniques was carried out.

Combined Therapy for Hepatocellular Carcinoma Larger than 3 cm

Transarterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) therapy has been used for patients with large hepatocellular carcinoma tumors, but the survival benefits of combining treatment are not known.

Treatment of Early Neoplasia in Barrett's Esophagus

To compare endoscopic therapy and esophagectomy in treatment of early neoplasia in Barrett's esophagus, a retrospective review from a single tertiary referral center was carried out.

Pancreatic Cancer-Associated Diabetes Mellitus

In order to evaluate the clinical profile of pancreatic cancer (PaC) associated diabetes (DM), the prevalence and clinical characteristics of DM in subjects with and without PaC were compared.